Status:
COMPLETED
Liposomal Bupivacaine in Bariatric Surgery
Lead Sponsor:
Montefiore Medical Center
Conditions:
Bariatric Surgery Analgesia
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The aim of this study is to perform a randomized controlled trial for patients undergoing bariatric surgery, comparing the need for opiates with and without administration of a transversus abdominis p...
Detailed Description
A prospective randomized controlled trial investigating the use of long acting local anesthetic for transversus abdominis block in patients undergoing bariatric surgery at Montefiore Medical Center. P...
Eligibility Criteria
Inclusion
- Obese patients undergoing bariatric surgery (LSG or LRYGB)
- Patients 18 years of age and older
- Surgical treatment between 01/01/2018 and 12/31/2018 over a 1 year period
Exclusion
- Patients under the age of 18 years old
- Patients taking any opiates within 30 days of enrollment in the trial
- Patients with a history of chronic pain.
- Patients taking pregabalin or gabapentin.
- ASA IV
- Prior laparotomy
- Body Mass Index ≥ 60 kg/m2
- History of cardiac arrhythmia
- History of Seizure
- Psychiatric Diagnosis currently on antipsychotic medication
Key Trial Info
Start Date :
January 30 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2018
Estimated Enrollment :
219 Patients enrolled
Trial Details
Trial ID
NCT03373591
Start Date
January 30 2018
End Date
December 31 2018
Last Update
November 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montefiore Medical Center
The Bronx, New York, United States, 10467